PF-00868554

· Pfizer

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for PF-00868554, covering 2009-03-09 to 2014-02-17. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Study Of PF-00868554 In Hepatitis C Virus (HCV) Positive Patients [Phase 1]